Jrsis Health Care Stock Performance
| JRSS Stock | USD 0.15 0.02 11.76% |
The company retains a Market Volatility (i.e., Beta) of 0.46, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, JRSIS Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding JRSIS Health is expected to be smaller as well. At this point, JRSIS Health Care has a negative expected return of -0.19%. Please make sure to check out JRSIS Health's jensen alpha and rate of daily change , to decide if JRSIS Health Care performance from the past will be repeated at future time.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days JRSIS Health Care has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors. ...more
| Begin Period Cash Flow | 844.8 K | |
| Total Cashflows From Investing Activities | -5.5 M |
JRSIS |
JRSIS Health Relative Risk vs. Return Landscape
If you would invest 40.00 in JRSIS Health Care on September 21, 2024 and sell it today you would lose (25.00) from holding JRSIS Health Care or give up 62.5% of portfolio value over 90 days. JRSIS Health Care is currently does not generate positive expected returns and assumes 15.8752% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than JRSIS, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
JRSIS Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for JRSIS Health's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as JRSIS Health Care, and traders can use it to determine the average amount a JRSIS Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0121
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | JRSS |
Estimated Market Risk
| 15.88 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.19 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average JRSIS Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of JRSIS Health by adding JRSIS Health to a well-diversified portfolio.
JRSIS Health Fundamentals Growth
JRSIS Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of JRSIS Health, and JRSIS Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on JRSIS Pink Sheet performance.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0911 | |||
| Profit Margin | (0.75) % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 3.28 M | |||
| Shares Outstanding | 58.37 M | |||
| Price To Earning | 0.48 X | |||
| Price To Book | 3.80 X | |||
| Price To Sales | 0.09 X | |||
| Revenue | 44.39 M | |||
| EBITDA | 8.11 M | |||
| Cash And Equivalents | 37.66 K | |||
| Total Debt | 26.97 K | |||
| Debt To Equity | 0.03 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | 8.23 M | |||
| Earnings Per Share | 0.11 X | |||
| Total Asset | 75.69 M | |||
About JRSIS Health Performance
Assessing JRSIS Health's fundamental ratios provides investors with valuable insights into JRSIS Health's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the JRSIS Health is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
JRSIS Health Care Corporation provides a range of medical services in Harbin in the Heilongjiang Province of the Peoples Republic of China. JRSIS Health Care Corporation was founded in 2006 and is based in Harbin, the Peoples Republic of China. Jrsis Health operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 963 people.Things to note about JRSIS Health Care performance evaluation
Checking the ongoing alerts about JRSIS Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for JRSIS Health Care help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| JRSIS Health Care generated a negative expected return over the last 90 days | |
| JRSIS Health Care has high historical volatility and very poor performance | |
| JRSIS Health Care has some characteristics of a very speculative penny stock |
- Analyzing JRSIS Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether JRSIS Health's stock is overvalued or undervalued compared to its peers.
- Examining JRSIS Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating JRSIS Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of JRSIS Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of JRSIS Health's pink sheet. These opinions can provide insight into JRSIS Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for JRSIS Pink Sheet Analysis
When running JRSIS Health's price analysis, check to measure JRSIS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy JRSIS Health is operating at the current time. Most of JRSIS Health's value examination focuses on studying past and present price action to predict the probability of JRSIS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move JRSIS Health's price. Additionally, you may evaluate how the addition of JRSIS Health to your portfolios can decrease your overall portfolio volatility.